

Please try another search
Milestone Pharmaceuticals Inc . (NASDAQ:MIST) has filed for up to 13,888,850 share offering by selling stockholders.
Investing.com - Milestone Pharmaceuticals (NASDAQ: MIST) reported first quarter EPS of $-0.350, $0.05 better than the analyst estimate of $-0.403. Revenue for the quarter came in at $1M versus the...
Investing.com - Milestone Pharmaceuticals (NASDAQ: MIST) reported first quarter EPS of $-0.310, $0.03 better than the analyst estimate of $-0.340. Revenue for the quarter came in at $3.5M versus the...
Investing.com - Milestone Pharmaceuticals (NASDAQ:MIST) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations. Milestone Pharmaceuticals...
Milestone Pharmaceuticals Inc . (NASDAQ:MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results...
Investing.com – U.S. stocks were lower after the close on Thursday, as losses in the Technology, Consumer Services and Healthcare sectors led shares lower. At the close in NYSE, the Dow Jones...
Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Oil & Gas, Technology and Utilities sectors led shares higher. At the close in NYSE, the Dow Jones Industrial...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review